Impairment Calculator
Belgium

IAS 36 impairment testing in Belgium: IAS 36 as adopted by the EU (for IFRS reporters); Belgian GAAP (Royal Decree of 30 January 2001) for non-IFRS reporters

Belgium's financial reporting requirements follow the EU-wide pattern: listed entities on Euronext Brussels apply EU-adopted IFRS (including IAS 36), while non-listed entities use Belgian GAAP as set out in the Royal Decree of 30 January 2001 and subsequent amendments. Belgian GAAP takes a conservative approach to asset measurement. Fixed assets are carried at historical cost less depreciation, and write-downs are required when an asset's value has permanently declined below its carrying amount. Unlike IAS 36, Belgian GAAP doesn't define "recoverable amount" or require a formal VIU calculation. The impairment test is simpler: has the asset's value permanently fallen below book value? The judgment of "permanent" is less structured than IAS 36's framework. Belgium hosts a significant number of multinational headquarters (particularly in pharmaceuticals, chemicals, food and beverages) and European institutions. Belgian auditors (bedrijfsrevisoren/réviseurs d'entreprises) working on IFRS engagements encounter IAS 36 models that often span multiple jurisdictions. The FSMA, as the securities regulator, reviews listed companies' financial statements and has addressed impairment disclosures in its periodic reports. Belgium's bilingual (and in some cases trilingual) business environment adds a practical dimension: impairment models, board minutes approving forecasts, and expert reports may be in Dutch, French, or English, and the audit team must work across all of them.

Regulatory context: Financial Services and Markets Authority (FSMA); College van Toezicht op de Bedrijfsrevisoren / Collège de Supervision des Réviseurs d'Entreprises (CTR/CSR) for audit oversight

The FSMA has raised impairment testing as a focus area in its annual reports on financial reporting by listed companies. Its 2022 report noted that several Belgian listed entities provided insufficient IAS 36.134 disclosures, particularly around the sensitivity of goodwill impairment tests to changes in key assumptions. The FSMA observed that some entities disclosed that they had performed sensitivity analysis but did not disclose the results or the range of assumptions tested. The CTR/CSR (the Belgian audit oversight body) has also identified impairment testing in its inspection findings, noting that auditors sometimes rely on the prior year's assessment of CGU boundaries without confirming that the current year's operational structure still supports those boundaries. The IBR-IRE (Institut des Réviseurs d'Entreprises/Instituut van de Bedrijfsrevisoren) publishes technical guidance that Belgian auditors reference for impairment testing work. Belgian audit practice is also influenced by cross-border coordination: many Belgian-headquartered groups have their audits coordinated from Belgium but with component auditors in multiple countries. The group auditor's responsibility under ISA 600 includes ensuring that component auditors perform adequate impairment testing work at the CGU level, which requires clear instructions about assumptions and methodology.

Practical guidance for Belgium

Belgian entities derive discount rates using eurozone inputs. The risk-free rate is typically based on Belgian OLO (Obligations Linéaires/Lineaire Obligaties) yields, which trade close to French OATs. The equity risk premium for the Belgian market is estimated at 5.5% to 6.5%, consistent with broader European averages. For mid-market Belgian entities with purely domestic operations, the WACC derivation is relatively straightforward. For the numerous Belgian-headquartered multinationals, the challenge is the same as for Dutch and French groups: each CGU needs a rate reflecting its specific country and industry risk. Belgian entities typically prepare multi-year business plans (often three to five years) approved by the board of directors. These plans serve as the IAS 36.33(a) basis for VIU projections. The terminal growth rate for Belgian domestic CGUs should align with long-term Belgian GDP growth, which the National Bank of Belgium (NBB) projects at approximately 1.2% to 1.5% nominal. For food and beverage companies (one of Belgium's strongest sectors), growth may exceed this where the entity has significant export markets.

Audit expectations

The CTR/CSR expects Belgian auditors to demonstrate independent work on impairment testing, consistent with ISA 540 requirements. For group audits, the CTR/CSR pays attention to the group auditor's instructions to component auditors regarding impairment: are the instructions specific enough to ensure consistent methodology? Do the component auditors report back with sufficient detail on their CGU-level testing? The CTR/CSR has flagged cases where component auditors performed impairment testing using different discount rate methodologies than the group auditor specified, creating inconsistency within the group's impairment testing framework.

Belgium-specific considerations

Belgian tax law allows goodwill amortisation as a tax deduction, typically over five years. This creates a timing difference between the tax base and accounting carrying amount under IAS 36 (where goodwill is not amortised under IFRS). When IAS 36 requires an impairment charge, the tax base (which has been reducing through amortisation) may already be below the pre-impairment accounting carrying amount, reducing the deferred tax impact of the charge. Belgium's "notional interest deduction" (NID, the allowance for corporate equity/aftrek voor risicokapitaal) provides a tax deduction based on the entity's equity. An impairment charge reduces equity and therefore reduces future NID benefits. This downstream tax effect doesn't directly affect the IAS 36 calculation (which uses pre-tax cash flows and pre-tax discount rates) but is a practical consequence that management should consider when assessing the full financial impact of recognising an impairment loss.

Common inspection findings

Component auditors used different discount rate methodologies than specified by the group auditor, creating inconsistency in group-level impairment testing (CTR/CSR inspection 2022)

CGU boundaries from prior years were carried forward without verification that the current organisational structure still supported them (CTR/CSR inspection 2023)

IAS 36.134 sensitivity disclosures stated sensitivity was performed without disclosing results or assumption ranges tested (FSMA financial reporting review 2022)

Auditors did not assess whether management's forecast assumptions were consistent with observable market data for the entity's sector (CTR/CSR inspection 2023)

For Belgian-headquartered multinationals, country risk premiums for emerging market CGUs were not separately identified or documented (CTR/CSR inspection 2022)